Abbott has begun to compare three months of dual antiplatelet therapy (DAPT) to the current standard of 12 months after everolimus-eluting coronary stent implantation.

A new system that switches blood flow from a blocked artery in the leg to a nearby vein showed promising early results as an alternative to lower-limb amputation.

Nearly nine in 10 patients with atherosclerotic cardiovascular disease (ASCVD) could improve their cholesterol levels with oral-only treatment, according to a new study.

For the first time, researchers have employed local gene therapy to boost myocardial blood flow in areas that have impaired perfusion reserves. They have also determined that elevated plasma Lp(a) can serve as a biomarker to identify those individuals with refractory angina (RA) who can benefit from the experimental therapy, gene transfer of VEGF-DΔNΔC.

Sensome's connected stroke guidewire is designed to sense the composition of clots and relay that information into machine learning algorithms and then on to physicians.

As more states move toward legalizing marijuana, new research suggests serious cardiovascular risks are associated with the drug.

Although safety-net hospitals (SNHs) provide care for greater proportions of uninsured patients, in-hospital mortality rates related to percutaneous coronary interventions (PCIs) are only slightly higher than at other hospitals.

The incidence of stroke is declining in men but not women, a recent study suggests.